Quantis Biotechnology develops human biomaterials for advanced cell culture and tissue engineering. Their proprietary biofabrication process creates scalable, biocompatible proteins that mimic native extracellular matrix, enhancing cell adhesion and tissue model fidelity for researchers and medical device developers.
Funding
Funding not disclosed
Founders
Product
Problem
Developing advanced cell culture and tissue engineering models requires biomaterials that accurately mimic native human tissue environments. Current off-the-shelf solutions often lack the specific biological cues and structural integrity necessary for high-fidelity in vitro applications, limiting research reproducibility and the development of next-generation medical devices.
Solution
Quantis Biotechnology produces human biomaterials using a proprietary biofabrication process that yields scalable, biocompatible proteins with preserved biological functions. This platform enables the creation of advanced cell culture substrates and bioinks that closely replicate the native extracellular matrix. By utilizing human-derived inputs and maintaining the structural and fibrillar characteristics of collagen, Quantis provides researchers and developers with materials that enhance cell adhesion, proliferation, and tissue model fidelity. This approach supports the development of more realistic tissue models and innovative medical devices.
Target Audience
The primary customers are researchers in tissue engineering, regenerative medicine, and drug discovery, as well as medical device manufacturers seeking advanced biomaterials for in vitro applications.
Features
- Scalable production of human collagen extracellular matrix (ECM) derived from human cells.
- Bioinks formulated with human collagen and animal-free components for tissue engineering and bioprinting applications.
- QMatrix products contain fibrous type 1 collagen, hyaluronic acid, elastin, and fibronectin to promote cell adhesion and proliferation.
- QMatrix+ offers a blend of human collagen ECM and biocompatible polymers for 3D applications, including tissue bioprinting and scaffold development.
- Spher Plates are custom-designed plates for standardized spheroid formation in cell culture.
- The biofabrication process preserves the structural nature and fibrillar characteristics of human proteins.
- All materials are designed to be biocompatible and bioidentical to native human proteins.